Sanofi (SAN.PA)
Company Info
| ISIN | FR0000120578 |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Highlights
| Market Cap | €125.83B |
|---|---|
| EPS (TTM) | €3.36 |
| PE Ratio | 29.88 |
| PEG Ratio | 0.82 |
| Total Revenue (TTM) | €45.38B |
| Gross Profit (TTM) | €30.35B |
| EBITDA (TTM) | €11.32B |
| Year Range | €77.39 - €106.14 |
| Target Price | €106.90 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: SAN.PA vs. GSK, SAN.PA vs. VOO, SAN.PA vs. UHS, SAN.PA vs. SC0T.DE, SAN.PA vs. TTE, SAN.PA vs. ^GSPC, SAN.PA vs. SPY
Performance
Performance Chart
The chart shows the growth of an initial investment of €10,000 in Sanofi, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Sanofi had a return of 16.98% year-to-date (YTD) and 6.27% in the last 12 months. Over the past 10 years, Sanofi had an annualized return of 6.07%, while the S&P 500 had an annualized return of 11.71%, indicating that Sanofi did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 16.98% | 22.95% |
| 1 month | -2.08% | 4.39% |
| 6 months | 20.85% | 18.07% |
| 1 year | 6.27% | 37.09% |
| 5 years (annualized) | 7.92% | 14.48% |
| 10 years (annualized) | 6.07% | 11.71% |
Monthly Returns
The table below presents the monthly returns of SAN.PA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 4.01% | -5.86% | 3.49% | 2.33% | 0.44% | 0.20% | 5.99% | 6.16% | 1.68% | 16.98% | |||
| 2023 | -0.19% | -0.87% | 12.77% | -0.24% | -1.58% | 3.50% | -1.13% | 1.60% | 2.88% | -15.55% | -0.28% | 5.03% | 3.64% |
| 2022 | 4.71% | 0.78% | -1.03% | 9.37% | 2.18% | -3.06% | 0.90% | -15.46% | -4.60% | 11.39% | -0.97% | 3.89% | 5.51% |
| 2021 | -1.97% | -1.75% | 11.15% | 3.58% | 3.49% | 1.60% | -1.68% | 0.85% | -5.18% | 4.03% | -2.97% | 5.63% | 16.88% |
| 2020 | -2.98% | -3.47% | -4.52% | 11.29% | 1.78% | 3.56% | -2.32% | -4.16% | 0.54% | -9.33% | 9.49% | -7.09% | -8.92% |
| 2019 | 0.21% | -3.06% | 7.13% | -1.59% | -2.85% | 5.08% | -0.59% | 3.53% | 8.88% | -2.87% | 2.29% | 6.05% | 23.44% |
| 2018 | -1.02% | -8.56% | 0.46% | 0.70% | 4.57% | 4.60% | 8.33% | -0.91% | 3.89% | 2.98% | 1.23% | -5.20% | 10.39% |
| 2017 | -3.13% | 9.18% | 4.05% | 2.35% | 5.17% | -5.00% | -3.63% | 1.16% | 2.88% | -3.24% | -5.77% | -6.20% | -3.48% |
| 2016 | -2.61% | -4.39% | -3.18% | 1.76% | 6.56% | 1.67% | 1.64% | -9.30% | -2.07% | 4.91% | 7.26% | 1.04% | 2.02% |
| 2015 | 8.38% | 6.95% | 4.82% | -0.79% | 0.91% | -1.02% | 11.03% | -10.00% | -3.72% | 8.20% | -8.13% | -6.85% | 7.24% |
| 2014 | -5.60% | 3.48% | 0.46% | 3.09% | 4.28% | -1.10% | 1.34% | 6.21% | 7.26% | -17.75% | 5.70% | -2.83% | 1.76% |
| 2013 | 0.66% | 1.00% | 9.22% | 4.98% | 2.45% | -3.50% | 0.69% | -9.33% | 3.14% | 4.76% | -0.89% | -0.92% | 11.63% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of SAN.PA is 44, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Sanofi (SAN.PA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Sanofi granted a 3.73% dividend yield in the last twelve months. The annual payout for that period amounted to €3.76 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | €3.76 | €3.56 | €3.33 | €3.20 | €3.15 | €3.07 | €3.03 | €2.96 | €2.93 | €2.85 | €2.80 | €2.77 |
Dividend yield | 3.73% | 3.97% | 3.71% | 3.63% | 4.02% | 3.44% | 4.03% | 4.14% | 3.83% | 3.65% | 3.72% | 3.61% |
Monthly Dividends
The table displays the monthly dividend distributions for Sanofi. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | €0.00 | €0.00 | €0.00 | €0.00 | €3.76 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €3.76 | ||
| 2023 | €0.00 | €0.00 | €0.00 | €0.00 | €3.56 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €3.56 |
| 2022 | €0.00 | €0.00 | €0.00 | €0.00 | €3.33 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €3.33 |
| 2021 | €0.00 | €0.00 | €0.00 | €0.00 | €3.20 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €3.20 |
| 2020 | €0.00 | €0.00 | €0.00 | €0.00 | €3.15 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €3.15 |
| 2019 | €0.00 | €0.00 | €0.00 | €0.00 | €3.07 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €3.07 |
| 2018 | €0.00 | €0.00 | €0.00 | €0.00 | €3.03 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €3.03 |
| 2017 | €0.00 | €0.00 | €0.00 | €0.00 | €2.96 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.96 |
| 2016 | €0.00 | €0.00 | €0.00 | €0.00 | €2.93 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.93 |
| 2015 | €0.00 | €0.00 | €0.00 | €0.00 | €2.85 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.85 |
| 2014 | €0.00 | €0.00 | €0.00 | €0.00 | €2.80 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.80 |
| 2013 | €2.77 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.77 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Sanofi. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Sanofi was 50.84%, occurring on Feb 13, 2003. Recovery took 2405 trading sessions.
The current Sanofi drawdown is 4.67%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -50.84% | Dec 28, 2001 | 287 | Feb 13, 2003 | 2405 | Jul 2, 2012 | 2692 |
| -33.16% | Aug 6, 2015 | 134 | Feb 11, 2016 | 980 | Dec 10, 2019 | 1114 |
| -32.71% | Mar 5, 1992 | 571 | Jun 21, 1994 | 268 | Jul 25, 1995 | 839 |
| -26.42% | Aug 1, 1997 | 62 | Oct 28, 1997 | 42 | Dec 30, 1997 | 104 |
| -25.34% | May 26, 2022 | 88 | Sep 26, 2022 | 148 | Apr 25, 2023 | 236 |
Volatility
Volatility Chart
The current Sanofi volatility is 4.29%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Sanofi compared to its peers in the Drug Manufacturers - General industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for SAN.PA in comparison to other companies of the Drug Manufacturers - General industry. Currently, SAN.PA has a PE value of 29.9. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for SAN.PA in comparison to other companies of the Drug Manufacturers - General industry. Currently, SAN.PA has a PEG value of 0.8. This PEG ratio falls in the average range for the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Sanofi.
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |